Home > News > Latest > "Lupin receives USFDA approval for generic drug to treat sleep disorders "

"Lupin receives USFDA approval for generic drug to treat sleep disorders "

Pharmaceuticals (LPI), US subsidiary of Indian drug maker Lupin, has received the US Food and Drug Administration's (FDA) approval for its Armodafinil tablets indicated to improve wakefulness in adult patients with obstructive sleep apnea, narcolepsy or shift work disorder. Armodafinil is a generic version of Cephalon Inc's Nuvigil tablets.